These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35256755)

  • 1. Cancer and its predictors in Chinese adults with newly diagnosed diabetes and impaired glucose tolerance (IGT): a 30-year follow-up of the Da Qing IGT and Diabetes Study.
    He S; Wang J; Shen X; Qian X; An Y; Gong Q; Zhang B; Chen B; Zhang L; Chen X; Chen Y; Li G
    Br J Cancer; 2022 Jul; 127(1):102-108. PubMed ID: 35256755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
    Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
    Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
    Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.
    Pan XR; Hu YH; Li GW; Liu PA; Bennett PH; Howard BV
    Diabetes Care; 1993 Jan; 16(1):150-6. PubMed ID: 8422770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3-6-year cohort study in southern Thailand.
    Jaruratanasirikul S; Thammaratchuchai S; Puwanant M; Mo-Suwan L; Sriplung H
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1267-1275. PubMed ID: 27740930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Type 2 Diabetes is Higher among Men with Persistent Impaired Glucose Tolerance than in Transient Impaired Glucose Tolerance - A 5 year Follow up Study.
    Raghavan A; Nanditha A; Snehalatha C; Vinitha R; Susairaj P; Simon M; Selvam S; Satheesh K; Ram J; Kumar APN; Godsland IF; Oliver N; Johnston DG; Ramachandran A
    J Assoc Physicians India; 2018 Oct; 66(10):22-26. PubMed ID: 31317702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical diabetes confirmed by 75-g OGTT influence on the prognosis of decompensated cirrhosis.
    Kang SH; Kim MY; Han SK; Baik SK
    J Gastroenterol Hepatol; 2024 Jan; 39(1):172-179. PubMed ID: 37697655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).
    Yang G; Li C; Gong Y; Fang F; Tian H; Li J; Cheng X
    J Diabetes Res; 2016; 2016():9270768. PubMed ID: 26770991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.